Related Experiment Video
Updated: Mar 20, 2026
12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Published on: September 7, 2022
2.2K
In vitro selection of antibiotic-binding aptamers
Florian Groher1, Beatrix Suess1
1Department of Biology, Technical University Darmstadt, Schnittspahnstr. 10, 64287 Darmstadt, Germany.
Methods (San Diego, Calif.)
|May 26, 2016
Summary
Selecting high-affinity RNA aptamers for small molecules remains difficult. This study presents a new in vitro selection protocol for antibiotic-binding aptamers, crucial for synthetic riboswitch design.
Area of Science:
- Molecular Biology
- Biochemistry
- Synthetic Biology
Background:
- RNA aptamer selection for small molecules presents significant challenges in achieving high affinity and specificity.
- Antibiotic-binding aptamers are key components in the development of synthetic riboswitches.
Purpose of the Study:
- To present a novel in vitro selection protocol for generating antibiotic-binding RNA aptamers.
- To compare the efficacy of the presented protocol against existing in vitro selection methods.
- To provide practical insights into the selection process, including tips and potential pitfalls.
Main Methods:
- In vitro selection (SELEX) for RNA aptamers targeting specific antibiotics.
- Comparative analysis of the developed protocol with alternative in vitro selection strategies.
- Detailed documentation of experimental procedures and optimization strategies.
Main Results:
- Successful selection of antibiotic-binding RNA aptamers using the novel protocol.
- Demonstration of the aptamers' potential as building blocks for synthetic riboswitches.
- Identification of advantages and limitations compared to other selection methods.
Conclusions:
- The presented in vitro selection protocol offers a viable method for obtaining high-affinity antibiotic-binding RNA aptamers.
- This protocol facilitates the design and construction of synthetic riboswitches.
- The study provides valuable guidance for researchers engaged in aptamer selection and synthetic biology.
